Brittany M Charlton1,2,3, Edward Giovannucci4,5,6, Charles S Fuchs7, Andrew T Chan6,8, Jung Eun Lee9, Yin Cao5, Stacey A Missmer4,6,10, Bernard A Rosner6, Susan E Hankinson4,6,11, Walter Willett4,5,6, Kana Wu5, Karin B Michels4,6,12. 1. Department of Epidemiology, Harvard T.H. Chan School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. bcharlton@mail.harvard.edu. 2. Division of Adolescent and Young Adult Medicine, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA, 02115, USA. bcharlton@mail.harvard.edu. 3. Department of Pediatrics, Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA. bcharlton@mail.harvard.edu. 4. Department of Epidemiology, Harvard T.H. Chan School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. 5. Department of Nutrition, Harvard T.H. Chan School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. 6. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA, 02115, USA. 7. Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02115, USA. 8. Division of Gastroenterology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA. 9. Department of Food and Nutrition, Sookmyung Women's University, Cheongpa-ro 47-gil 100, Yongsan-gu, Seoul, 04310, South Korea. 10. Division of Reproductive Medicine, Brigham and Women's Hospital and Harvard Medical School, 45 St. Francis Street, Boston, MA, 02115, USA. 11. Division of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts, 715 North Pleasant Street, Amherst, MA, 01003, USA. 12. Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, 221 Longwood Avenue, Boston, MA, 02115, USA.
Abstract
PURPOSE: The influence of reproductive factors on colorectal cancer, including oral contraceptive (OC) use, has been examined, but less research is available on OC use and adenomas. METHODS: Participants of the Nurses' Health Study who had a lower bowel endoscopy between 1986 (when endoscopies were first assessed) and 2008 were included in this study. Multivariable logistic regression models for clustered data were used to estimate odds ratios and 95 % confidence intervals [OR (95 % CIs)]. RESULTS: Among 73,058 participants, 51 % (n = 37,382) reported ever using OCs. Ever OC use was associated with a slight increase in non-advanced adenomas [OR 1.11, 95 % CI (1.02, 1.21)] but not with any other endpoints. Duration of OC use was not associated with adenomas, but longer times since last OC use were associated with increased odds of adenomas [e.g., compared to never use, 15+ years since last use: OR 1.17 (1.07, 1.27)]. Shorter times since last OC use were inversely associated [e.g., ≤4 years since last use: OR 0.74 (0.65, 0.84)]. CONCLUSIONS: We observed a modest borderline increase in risk of colorectal adenomas with any prior OC use. Additionally, more recent OC use may decrease risk, while exposure in the distant past may modestly increase risk of adenomas.
PURPOSE: The influence of reproductive factors on colorectal cancer, including oral contraceptive (OC) use, has been examined, but less research is available on OC use and adenomas. METHODS:Participants of the Nurses' Health Study who had a lower bowel endoscopy between 1986 (when endoscopies were first assessed) and 2008 were included in this study. Multivariable logistic regression models for clustered data were used to estimate odds ratios and 95 % confidence intervals [OR (95 % CIs)]. RESULTS: Among 73,058 participants, 51 % (n = 37,382) reported ever using OCs. Ever OC use was associated with a slight increase in non-advanced adenomas [OR 1.11, 95 % CI (1.02, 1.21)] but not with any other endpoints. Duration of OC use was not associated with adenomas, but longer times since last OC use were associated with increased odds of adenomas [e.g., compared to never use, 15+ years since last use: OR 1.17 (1.07, 1.27)]. Shorter times since last OC use were inversely associated [e.g., ≤4 years since last use: OR 0.74 (0.65, 0.84)]. CONCLUSIONS: We observed a modest borderline increase in risk of colorectal adenomas with any prior OC use. Additionally, more recent OC use may decrease risk, while exposure in the distant past may modestly increase risk of adenomas.
Entities:
Keywords:
Adenoma; Colorectal neoplasms; Contraceptives; Intestinal polyps; Oral; Reproductive history
Authors: Jennifer Lin; Shumin M Zhang; Nancy R Cook; Joann E Manson; Julie E Buring; I-Min Lee Journal: Am J Epidemiol Date: 2007-01-10 Impact factor: 4.897
Authors: R M Bostick; J D Potter; L H Kushi; T A Sellers; K A Steinmetz; D R McKenzie; S M Gapstur; A R Folsom Journal: Cancer Causes Control Date: 1994-01 Impact factor: 2.506
Authors: M L Slattery; Rachel Ballard-Barbash; Sandra Edwards; Bette J Caan; John D Potter Journal: Cancer Causes Control Date: 2003-02 Impact factor: 2.506
Authors: Sheetal Hardikar; Andrea N Burnett-Hartman; Jessica Chubak; Melissa P Upton; Lee-Ching Zhu; John D Potter; Polly A Newcomb Journal: Cancer Causes Control Date: 2017-02-15 Impact factor: 2.506